Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Regenerex Pharma (RGPX) Capital Expenditures (2017 - 2023)

Regenerex Pharma (RGPX) reported Capital Expenditures of $2670.0 for Q3 2023, down 26.43% on a QoQ basis from $3629.0 in Q2 2023.

Regenerex Pharma (RGPX) has 3 years of Capital Expenditures data on file, last reported at $2670.0 in Q3 2023.

  • Quarterly Capital Expenditures changed N/A year-over-year to $2670.0 in Q3 2023, while the trailing twelve-month figure through Mar 2024 was $6299.0 (up 109.97% YoY) and the FY2025 annual result came in at $1228.0, down 80.5% from the prior year.
  • Capital Expenditures slipped to $2670.0 in Q3 2023 per RGPX's latest filing, from $3629.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $3629.0 in Q2 2023 and bottomed at $2670.0 in Q3 2023.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 2,670.00
Sep 30, 2023 2,670.00
Jun 30, 2023 3,629.00
Jun 30, 2023 3,629.00
Dec 31, 2021 3,000.00
Dec 31, 2021 3,000.00
Jun 30, 2017 16,000.00
Jun 30, 2017 16,000.00